Balance Sheet Data

Adaptimmune Therapeutics PLC

Adaptimmune Therapeutics PLC (ADAP)

$4.53
0.13 (+2.95%)

Year
A/P
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
Total Cash 248.88181.47208.26205.1389.5442.3361.7890.16131.58192.02
Total Cash (%)
Account Receivables 0.741.480.2118.1620.676.209.0413.2019.2628.11
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 7.8811.358.384.086.362.503.655.327.7711.34
Accounts Payable (%)
Capital Expenditure -9.84-12.79-25.01-4.71-3.07-1.79-2.62-3.82-5.57-8.14
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.